Benzinga’s Top Ratings Upgrades, Downgrades For December 30, 2022
Upgrades See all analyst ratings upgrades. Downgrades For Micron Technology Inc (NASDAQ:MU), Argus Research downgraded the previous rating…
Benzinga’s Top Ratings Upgrades, Downgrades For December 29, 2022
Upgrades CFRA upgraded the previous rating for Netflix Inc (NASDAQ:NFLX) from Sell to Buy. Netflix earned $3.10 in…
HC Wainwright & Co. Downgrades Loop Industries to Neutral
HC Wainwright & Co. analyst Amit Dayal downgrades Loop Industries (NASDAQ:LOOP) from Buy to Neutral.
Benzinga’s Top Ratings Upgrades, Downgrades For December 28, 2022
Upgrades See all analyst ratings upgrades. Downgrades See all analyst ratings downgrades. Initiations Capital One initiated coverage on…
SVB Leerink Downgrades Applied Molecular to Market Perform, Lowers Price Target to $2
SVB Leerink analyst Joseph Schwartz downgrades Applied Molecular (NASDAQ:AMTI) from Outperform to Market Perform and lowers the price target from $15 to $2.
Benzinga’s Top Ratings Upgrades, Downgrades For December 23, 2022
Upgrades For The Toro Co (NYSE:TTC), Raymond James upgraded the previous rating of Market Perform to Outperform. For…
Loop Capital Downgrades Paramount Global to Sell, Lowers Price Target to $14
Loop Capital analyst Alan Gould downgrades Paramount Global (NASDAQ:PARA) from Hold to Sell and lowers the price target from $30 to $14.
CIBC Downgrades AutoCanada to Neutral, Announces C$24 Price Target
CIBC analyst Krista Friesen downgrades AutoCanada (TSX:ACQ) from Outperformer to Neutral and announces C$24 price target.
Benzinga’s Top Ratings Upgrades, Downgrades For December 22, 2022
Upgrades According to DA Davidson, the prior rating for Helen Of Troy Ltd (NASDAQ:HELE) was changed from Neutral…
Oppenheimer Downgrades Fate Therapeutics to Perform
Oppenheimer analyst Matthew Biegler downgrades Fate Therapeutics (NASDAQ:FATE) from Outperform to Perform.